TransEnterix

TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options. The Company is focused on the commercialization of the Senhance Surgical Robotic System, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye sensing camera control. The Company also developed the SurgiBot™ System, a single-port, robotically enhanced laparoscopic surgical platform.

Company Growth (employees)
Type
Public
HQ
Morrisville, US
Founded
2006
Size (employees)
103 (est)
TransEnterix was founded in 2006 and is headquartered in Morrisville, US

Key People at TransEnterix

Todd M. Pope

Todd M. Pope

President & CEO

TransEnterix Office Locations

TransEnterix has offices in Morrisville and Trezzano Rosa
Morrisville, US (HQ)
300 635 Davis Dr
Trezzano Rosa, IT
40 Via Firenze

TransEnterix Data and Metrics

TransEnterix Financial Metrics

TransEnterix's revenue was reported to be $1.9 m in Q1, 2017
USD

Revenue (Q1, 2017)

1.9 m

Gross profit (Q1, 2017)

612 k

Gross profit margin (Q1, 2017), %

31%

Net income (Q1, 2017)

(15.4 m)

EBIT (Q1, 2017)

(15.9 m)

Market capitalization (21-Sep-2017)

172.1 m

Cash (31-Mar-2017)

13.1 m
TransEnterix's current market capitalization is $172.1 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.4 m401 k1.5 m

Revenue growth, %

(72%)(100%)

Cost of goods sold

4.8 m1.1 m1.1 m

Gross profit

(3.4 m)(694 k)450 k
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

113 k61 k93 k113 k61 k1.5 m1.9 m

Cost of goods sold

238 k202 k220 k238 k202 k1 m1.3 m

Gross profit

(125 k)(141 k)(127 k)(125 k)(141 k)435 k612 k

Gross profit Margin, %

(111%)(231%)(137%)(111%)(231%)30%31%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

10 m34.8 m38.4 m24.2 m

Accounts Receivable

188 k133 k76 k621 k

Inventories

3.9 m7.9 m

Current Assets

17.8 m35.7 m49.1 m38 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

52.6 m44.3 m28.4 m71.1 m52.9 m53.5 m64.6 m42.5 m13.1 m

Accounts Receivable

96 k38 k53 k8 k78 k79 k77 k616 k1.8 m

Inventories

438 k267 k3.4 m3.6 m4.2 m2.3 m8.3 m

Current Assets

53.7 m45.5 m29.1 m71.7 m61.9 m64.3 m76 m53.5 m28.8 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(28.4 m)(37.7 m)(46.9 m)(120 m)

Depreciation and Amortization

1.5 m1.3 m2.2 m7 m

Accounts Receivable

402 k55 k133 k(1 m)

Inventories

731 k701 k(1.9 m)(6.6 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(18.1 m)(29.6 m)(10.1 m)(19.5 m)(33.4 m)(12.9 m)(93 m)(106 m)(15.4 m)

Depreciation and Amortization

594 k936 k390 k768 k1.4 m2.4 m4.7 m6.8 m2.2 m

Accounts Receivable

92 k150 k80 k125 k133 k80 k125 k(809 k)(753 k)

Inventories

263 k434 k50 k263 k(250 k)(1.7 m)(4 m)(1.9 m)(320 k)
USDY, 2017

Revenue/Employee

18.9 k

Financial Leverage

1.4 x
Show all financial metrics

TransEnterix Operating Metrics

TransEnterix's Patent Applications was reported to be 40 in FY, 2016
FY, 2016

Patent Applications

40

Patents Issued

19
Show all operating metrics

TransEnterix Market Value History

Traffic Overview of TransEnterix

TransEnterix Online and Social Media Presence

TransEnterix Company Life and Culture

You may also be interested in